As #AIDS2026 comes to a close, thank you to everyone who joined us at our sessions, visited our booth, stopped by our posters, and shared their perspectives throughout the week. Thank you, @iasociety.bsky.social. Until next time.

Great discussion at #AIDS2026 on accelerating the transition to #pALD for children living with HIV. Key message: innovation is only the first step. Success depends on access, country planning, community demand, empowered health workers and sustained advocacy. 🎥 Watch the recording: bit.ly/4fvR8iN

📍 Today at #AIDS2026 Today's MPP programme highlights how innovation can be translated into better health outcomes. 👉 medicinespatentpool.org/news-publica...

Thank you for joining our #AIDS2026 satellite session on HIV treatment access in LAC. From DTG/3TC to future long-acting options, one message stood out: innovation alone is not enough. Expanding access requires sustainable financing, strong health systems, community engagement and collaboration.

Thank you for our #AIDS2026 satellite session on HIV treatment access in LAC. From DTG/3TC to future long-acting options, one message stood out: innovation alone is not enough. Expanding access requires sustainable financing, strong health systems, community engagement and collaboration.

📍 Today at AIDS 2026 Today's discussions at MPP Booth #717 focus on improving HIV treatment access and outcomes for children and young people. 🔗 medicinespatentpool.org/news-publica...

#WorldHepatitisDay2026 Charles Gore's message is clear: eliminating viral hepatitis by 2030 is off track. Despite affordable testing and treatment, too many people remain undiagnosed and untreated. The tools exist, we need the political will to use them. 👉 medicinespatentpool.org/news-publica...

📍 Today at #AIDS2026: 🔹 12:00–13:00: Poster: Access to quality, affordable WHO-recommended HIV treatment options beyond TLD in LMICs by @sebmoringva.bsky.social 🔹 18:00–19:30: Satellite session: Beyond TLD: Optimising newly recommended HIV treatment options for diverse needs in LAC bit.ly/4c6JARb

📍 AIDS 2026 starts now! This week, the @medicinespatentpool.org is joining partners, researchers, policymakers, community representatives and advocates from around the world in Rio de Janeiro. 🇧🇷 👋 Visit us at Booth #717 in the Exhibition Area! 🔗 medicinespatentpool.org/news-publica...

At #AIDS2026, we're highlighting reflections from members of MPP's Community Advisory Panel, whose lived experience and advocacy help ensure community realities shape access discussions. We're also seeking new CAP members, particularly from LAC: medicinespatentpool.org/rfp-vacancy/...

How do innovation, voluntary licensing & partnerships translate into broader access to HIV treatment? At #AIDS2026, MPP will present 2️⃣ posters exploring access to WHO-recommended HIV medicines in LMICs and access trends for DTG-based treatments through 2025. 🔗 medicinespatentpool.org/news-publica...

📍 Heading to #AIDS2026? Visit MPP at Booth #717 to discuss access to HIV medicines, voluntary licensing & our open-access tools. Join our booth conversations on pALD, youth leadership & translating innovation into impact. 🔗 medicinespatentpool.org/news-publica... @egpaf.bsky.social

📢 We're pleased to launch the first edition of the LAPaL newsletter 📬 Read the newsletter: mailchi.mp/medicinespat... and explore the database: lapal.ch 👉 Subscribe: lapal.ch/news @unitaid.bsky.social @coefficientgiving.bsky.social @liverpooluni.bsky.social @celtliverpool.bsky.social

@medicinespatentpool.org and @pentafoundation.bsky.social are pleased to announce the signing of a MoU to strengthen collaboration in support of equitable #access to priority health technologies for #children in LMICs. 👉 medicinespatentpool.org/partners/who... #AIDS2026

At #AIDS2026? Join us at the MPP booth (717) in the Exhibition area on 🗓️Wednesday 29 July from ⏰10:45. We'll be with our GAP-f partners discussing the transition to pALD ➡️ AFROCAB, @egpaf.bsky.social, PATA and @unitaid.bsky.social. #BetterMeds4Kids 🔗 medicinespatentpool.org/news-publica...

Elizabeth Glaser Pediatric AIDS Foundation@egpaf.bsky.social · 2w ago

We are excited to join Gap-F for a special conversation at the @medicinespatentpool.org booth at #AIDS2026. Join us on July 29 in the exhibition area for a conversation on what it will take to make the remaining transition to pALD smooth and fast. #BetterMeds4Kids @aidsconference.bsky.social

🌍 Heading to #AIDS2026 (Rio🇧🇷)? Join @medicinespatentpool.org, PAHO & @unitaid.bsky.social on 🗓️28 July ⏰18:00-19:30 BRT for a discussion on expanding HIV treatment options beyond TLD in Latin America and the Caribbean. 🔗 medicinespatentpool.org/news-publica... @aidsconference.bsky.social

📍 Heading to Rio for #AIDS2026? 🇧🇷 Our team will be contributing to discussions on access to HIV medicines, voluntary licensing, innovative treatment options and equitable access. Come and meet us at Booth #717 in the Exhibition Area! 👉 medicinespatentpool.org/news-publica...

Greater access to a single essential medicine often means that several conditions can be tackled at once. As Louie Zepeda-Teng, a health advocate from the Philippines explains, GLP-1 receptor agonists can help with diabetes and obesity, and also TB. 👉 medicinespatentpool.org/story-post/v...

📣 Join us at #ICO2026 for a discussion on equitable access to #obesity treatment. Equitable access to obesity treatment in LMICs: Aspirational goal or achievable public health priority? 📅 Wednesday 15 July 🕧 12:25–13:50 📍 World Trade Center Mexico City 👉 medicinespatentpool.org/news-publica...

✨ We're excited to be attending the #ICO2026 in Mexico City 🇲🇽 from 15–17 July. Our team will be on site throughout the congress and we look forward to connecting with you! 👉 medicinespatentpool.org/news-publica... @worldobesity.bsky.social

📢 Request for Proposals: Website Hosting, Maintenance, SEO & Digital Campaign Management Services 👉 medicinespatentpool.org/rfp-vacancy/... 🗓️ Proposal deadline: 31 August 2026 📄 Contract: 12 months, with the possibility of renewal

Request for Proposals: Website Hosting, Maintenance, SEO and Digital Campaign Management Services - MPP

medicinespatentpool.org

Long-acting #HIV medicines could transform treatment and prevention, but access in many LMICs remains limited. MPP speaks with Dr Charles Flexner about a roadmap to expand access to affordable generic long-acting antiretrovirals. 📖 medicinespatentpool.org/story-post/a...

Accelerating Access to Long-Acting HIV Medicines: A New Roadmap for Global Health - MPP

Long-acting HIV medicines have the potential to transform both treatment and prevention, reducing pill burden, improving adherence, and better reflecting what people living with or at risk of HIV cons...

medicinespatentpool.org

📢 RFP #Opportunity MPP is seeking a consultant to conduct a landscape assessment of Africa’s health emergency #preparedness and response ecosystem to support local manufacturing of #pandemic-relevant therapeutics. 👉 medicinespatentpool.org/rfp-vacancy/...

Request for Proposal: Landscape Assessment to Support Local Manufacturing of Pandemic-Relevant Therapeutics in Africa - MPP

medicinespatentpool.org

Our patents and licences database #MedsPaL includes powerful tools to explore health-related IP: - Advanced search filters - Detailed licence insights - Interactive maps, charts, and timelines 👉 medspal.org 👉 Tutorials: www.youtube.com/playlist?lis...

MedsPaL Tutorial Series - YouTube

youtube.com

A thank you to the members of our CAP! For the past three years, CAP members have helped shape access to medicines through their expertise, lived experience and community insight. 👉 We are opening the next chapter of the CAP: medicinespatentpool.org/rfp-vacancy/...

📢 Join our CAP Maureen Luba, public health specialist, global policy leader at AVAC, and community representative on MPP’s Board, shares why listening to communities is essential for better, more equitable decision-making. 👉 Statement: lnkd.in/eHuTzBir 👉 Apply here: lnkd.in/ekwHRJxt

At the 58th @unaids.org Programme Coordinating Board meeting, MPP highlighted the importance of ensuring that innovation reaches everyone who needs it. 👉 medicinespatentpool.org/news-publica... @who.int

📢 A new call for applications to join the CAP is now open. As the first 3-year term of MPP’s CAP has come to a close, we are celebrating the people who have brought community perspectives into the heart of how we think about access to medicines. 👉 lnkd.in/eHuTzBir 👉 lnkd.in/ekwHRJxt

📢 RFP #Opportunity MPP is seeking a consultant to conduct a landscape assessment of Africa’s health emergency #preparedness and response ecosystem to support local manufacturing of #pandemic-relevant therapeutics. 👉 medicinespatentpool.org/rfp-vacancy/...

Request for Proposal: Landscape Assessment to Support Local Manufacturing of Pandemic-Relevant Therapeutics in Africa - MPP

medicinespatentpool.org

How can publicly funded research deliver real public health impact? Ahead of key ITRE discussions, 50+ orgs urge Members of @europarl.europa.eu to integrate #AccessPlans into #HorizonEurope 2028–2034 — addressing access challenges early, not after launch. 👉 Read the joint letter bit.ly/4vp3PBg

More than 50 organisations call on the EU to ensure that medicines funded by public money are accessible

Many of the vaccines and medicines we rely on today would not exist without public funding. Universities, hospitals, research institutes and public bodies contribute every year to discoveries that lat...

bit.ly